DSGN logo

Design Therapeutics (DSGN) Cash From Investing

Annual CFI

$43.95 M
-$8.58 M-16.33%

December 1, 2024


Summary


Performance

DSGN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDSGNcash flowmetrics:

Quarterly CFI

$1.83 M
+$7.66 M+131.45%

December 1, 2024


Summary


Performance

DSGN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDSGNcash flowmetrics:

TTM CFI

$43.95 M
-$3.72 M-7.81%

December 1, 2024


Summary


Performance

DSGN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDSGNcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

DSGN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.3%+131.4%-7.8%
3 y3 years+181.9%+131.4%-7.8%
5 y5 years+100.0%+131.4%-7.8%

DSGN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.3%+119.9%-93.3%+101.2%-36.1%+116.3%
5 y5-year-16.3%+119.9%-93.3%+101.2%-36.1%+116.3%
alltimeall time-16.3%+119.9%-93.3%+101.2%-36.1%+116.3%

Design Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
$43.95 M(-16.3%)
$1.83 M(-131.4%)
$43.95 M(-7.8%)
Sep 2024
-
-$5.83 M(-121.3%)
$47.68 M(-30.7%)
Jun 2024
-
$27.33 M(+32.6%)
$68.77 M(+28.7%)
Mar 2024
-
$20.62 M(+271.1%)
$53.42 M(+1.7%)
Dec 2023
$52.54 M(-123.8%)
$5.55 M(-63.6%)
$52.54 M(+14.4%)
Sep 2023
-
$15.27 M(+27.4%)
$45.92 M(-240.3%)
Jun 2023
-
$11.98 M(-39.3%)
-$32.73 M(-83.8%)
Mar 2023
-
$19.73 M(-1968.7%)
-$201.67 M(-8.7%)
Dec 2022
-$220.99 M
-$1.06 M(-98.3%)
-$220.99 M(-18.1%)
Sep 2022
-
-$63.39 M(-59.6%)
-$269.99 M(+27.6%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$156.96 M(<-9900.0%)
-$211.64 M(+177.5%)
Mar 2022
-
$414.00 K(-100.8%)
-$76.26 M(+42.2%)
Dec 2021
-$53.64 M(+59.8%)
-$50.06 M(+892.8%)
-$53.64 M(+3280.2%)
Sep 2021
-
-$5.04 M(-76.6%)
-$1.59 M(-123.9%)
Jun 2021
-
-$21.57 M(-193.7%)
$6.64 M(-76.9%)
Mar 2021
-
$23.03 M(+1052.6%)
$28.71 M(-185.6%)
Dec 2020
-$33.56 M(<-9900.0%)
$2.00 M(-37.3%)
-$33.56 M(-5.6%)
Sep 2020
-
$3.19 M(+536.1%)
-$35.56 M(-8.2%)
Jun 2020
-
$501.00 K(-101.3%)
-$38.75 M(-1.3%)
Mar 2020
-
-$39.25 M
-$39.25 M
Dec 2019
$0.00
-
-

FAQ

  • What is Design Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Design Therapeutics?
  • What is Design Therapeutics annual CFI year-on-year change?
  • What is Design Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Design Therapeutics?
  • What is Design Therapeutics quarterly CFI year-on-year change?
  • What is Design Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Design Therapeutics?
  • What is Design Therapeutics TTM CFI year-on-year change?

What is Design Therapeutics annual cash flow from investing activities?

The current annual CFI of DSGN is $43.95 M

What is the all time high annual CFI for Design Therapeutics?

Design Therapeutics all-time high annual cash flow from investing activities is $52.54 M

What is Design Therapeutics annual CFI year-on-year change?

Over the past year, DSGN annual cash flow from investing activities has changed by -$8.58 M (-16.33%)

What is Design Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of DSGN is $1.83 M

What is the all time high quarterly CFI for Design Therapeutics?

Design Therapeutics all-time high quarterly cash flow from investing activities is $27.33 M

What is Design Therapeutics quarterly CFI year-on-year change?

Over the past year, DSGN quarterly cash flow from investing activities has changed by +$7.66 M (+131.45%)

What is Design Therapeutics TTM cash flow from investing activities?

The current TTM CFI of DSGN is $43.95 M

What is the all time high TTM CFI for Design Therapeutics?

Design Therapeutics all-time high TTM cash flow from investing activities is $68.77 M

What is Design Therapeutics TTM CFI year-on-year change?

Over the past year, DSGN TTM cash flow from investing activities has changed by -$3.72 M (-7.81%)